Free Trial

Harvest Fund Management Co. Ltd Acquires 15,826 Shares of Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Harvest Fund Management Co. Ltd increased its stake in Exelon Co. (NASDAQ:EXC - Free Report) by 52.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 46,086 shares of the company's stock after purchasing an additional 15,826 shares during the period. Harvest Fund Management Co. Ltd's holdings in Exelon were worth $1,868,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Los Angeles Capital Management LLC raised its holdings in shares of Exelon by 666.2% in the 2nd quarter. Los Angeles Capital Management LLC now owns 3,583,477 shares of the company's stock worth $124,024,000 after purchasing an additional 3,115,763 shares in the last quarter. Swedbank AB acquired a new stake in shares of Exelon during the 1st quarter valued at $96,859,000. International Assets Investment Management LLC raised its position in shares of Exelon by 4,103.5% during the third quarter. International Assets Investment Management LLC now owns 1,046,630 shares of the company's stock worth $42,441,000 after purchasing an additional 1,021,731 shares during the period. Robeco Institutional Asset Management B.V. boosted its position in shares of Exelon by 101.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,344,978 shares of the company's stock valued at $54,539,000 after purchasing an additional 678,490 shares during the period. Finally, Jennison Associates LLC increased its stake in Exelon by 44.0% in the 3rd quarter. Jennison Associates LLC now owns 1,830,435 shares of the company's stock worth $74,224,000 after purchasing an additional 558,977 shares in the last quarter. Institutional investors and hedge funds own 80.92% of the company's stock.

Exelon Price Performance

Shares of Exelon stock traded up $0.36 during midday trading on Tuesday, hitting $39.49. 5,591,498 shares of the company were exchanged, compared to its average volume of 6,738,144. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97. The firm has a 50 day simple moving average of $39.60 and a 200-day simple moving average of $37.85. Exelon Co. has a 52 week low of $33.35 and a 52 week high of $41.42. The firm has a market cap of $39.68 billion, a P/E ratio of 16.25, a PEG ratio of 2.76 and a beta of 0.54.

Exelon (NASDAQ:EXC - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.04. The company had revenue of $6.15 billion during the quarter, compared to analyst estimates of $5.85 billion. Exelon had a net margin of 10.60% and a return on equity of 9.47%. The company's revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the business posted $0.67 earnings per share. Research analysts forecast that Exelon Co. will post 2.46 earnings per share for the current year.

Exelon Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Monday, November 11th will be issued a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a yield of 3.85%. The ex-dividend date is Friday, November 8th. Exelon's dividend payout ratio is currently 62.55%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Barclays upped their price target on shares of Exelon from $41.00 to $44.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. Morgan Stanley dropped their price target on shares of Exelon from $46.00 to $44.00 and set an "equal weight" rating on the stock in a research note on Friday. Jefferies Financial Group began coverage on Exelon in a research note on Thursday, September 19th. They issued a "buy" rating and a $46.00 price objective on the stock. UBS Group upped their target price on Exelon from $40.00 to $43.00 and gave the stock a "neutral" rating in a research report on Friday, September 20th. Finally, Scotiabank upped their price target on shares of Exelon from $37.00 to $40.00 and gave the company a "sector perform" rating in a report on Tuesday, August 20th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $41.25.

Check Out Our Latest Stock Analysis on EXC

Exelon Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Read More

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should you invest $1,000 in Exelon right now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines